Positron Emission Tomography Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Positron Emission Tomography (PET) Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Positron Emission Tomography (PET) Market
Research Report The latest report by IMARC,
titled Positron Emission Tomography (PET)
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2023-2028 the
global positron emission tomography (PET) market
is expected to exhibit a CAGR of 5.9 during
2023-2028. Positron emission tomography (PET)
is a nuclear medicine procedure that aids in
measuring the metabolic activity of the cells. In
this procedure, a tiny amount of radioactive
glucose, known as a radiopharmaceutical or
radioactive tracer, is used to assist in the
examination of tissue. PET scans help to
visualize the biochemical changes taking place in
the body, such as the metabolism of the heart
muscle. They also generate a detailed image of
areas containing glucose, which helps in
assessing the functions of organs and tissues
effectively. Consequently, they are used for
evaluating several conditions, such as cancer,
heart diseases and brain disorders. Request Free
Sample Report https//www.imarcgroup.com/positron
-emission-tomography-market/requestsample
4
Report Description and Highlights
Report Description

Global Positron Emission Tomography (PET) Market
Trends PET imaging has evolved from an imaging
modality used for research to a standard
component of diagnosing and staging in oncology
and specific neurological and cardiovascular
indications. The sudden outbreak of the
coronavirus disease (COVID-19) has further
increased the use of PET imaging as it supports
the development of novel therapeutics and helps
in the study of the pathogenesis of SARS-CoV-2,
the COVID-19 virus. Furthermore, modern systems
have been introduced that utilize gamma camera
systems. They can complete a scan more quickly
and at a lower cost than a traditional PET scan.
With advancements in PET technologies, it is
being used in conjunction with other diagnostic
tests, such as computed tomography (CT) or
magnetic resonance imaging (MRI) to provide more
definitive information about cancerous tumors and
lesions. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product Type
Full Ring PET Scanners Partial Ring PE
T Scanners Breakup by Detector Type Bi
smuth Germanium Oxide (BGO) Lutetium Oxy
orthosilicate (LSO) Lutetium Fine Silica
te (LFS) Lutetium Yttrium Orthosilicate
(LYO) Gadolinium Oxyorthosilicate (GSO)
Breakup by Application Cardiology
Neurology Oncology Other
s Breakup by End-User

6
Report Description and Highlights
Report Description
Hospitals and Clinics
Diagnostic Centers Others Br
eakup by Region North America
United States Canada
Asia Pacific China
Japan India
South Korea Australia
Indonesia
Others Europe Germany
France United
Kingdom

7
Report Description and Highlights
Report Description
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Agfa Healthcare (Dedalus Group)
  GE Healthcare Koninklijke Philips NV Neusoft Medic
  al Systems Positron Corporation Oncovision (Bruker
  ) Mediso Medical Imaging Systems Ltd. Siemens Heal
  thineers AG Segami Corporation Hitachi Ltd.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/positron-emission-tomog
  raphy-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us